(Q41134063)

27 September 2017

Mucinous carcinoma in Crohn's disease originating in a fistulous tract (English)

1 reference

27 September 2017

1 reference

Hugh J Freeman

1

1 reference

27 September 2017

Tom Perry

2

1 reference

27 September 2017

Douglas L Webber

3

1 reference

27 September 2017

Silvia D Chang

4

1 reference

27 September 2017

Mong-Yang Loh

5

1 reference

27 September 2017

1 July 2010

1 reference

World journal of gastrointestinal oncology

27 September 2017

1 reference

27 September 2017

2

1 reference

27 September 2017

7

1 reference

27 September 2017

307-310

1 reference

Colorectal cancer risk in Crohn's disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

Adenocarcinoma arising from chronic perianal Crohn's disease: case report and review of the literature.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

Appendiceal carcinoids in Crohn's disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

Anti-TNF therapy and malignancy - a critical review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

Infliximab for the treatment of fistulas in patients with Crohn's disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

Carcinoma complicating Crohn's disease. Report of seven cases and review of the literature

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

Development of adenocarcinoma in chronic fistula in Crohn's disease.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

Closing fistulas in Crohn's disease--should the accent be on maintenance or safety?

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

Tabulation of myeloid, lymphoid and intestinal malignancies in Crohn's disease

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

Carcinoma arising in anorectal fistulas of Crohn's disease.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999135

Colorectal cancer complicating Crohn's disease

19 August 2018

1 reference

12 December 2020

Adenocarcinoma in perineal fistulas of Crohn's disease

1 reference

12 December 2020

Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy

1 reference

12 December 2020

Crohn's colitis presenting with node-negative colon cancer and liver metastasis after therapy with infliximab: report of two cases

1 reference

12 December 2020

Carcinoid tumors are 15 times more common in patients with Crohn's disease

1 reference

12 December 2020

Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease

1 reference

12 December 2020

Cancer risk in patients with inflammatory bowel disease: a population-based study

1 reference

12 December 2020

Anorectal Carcinoma After Infliximab Therapy in Crohn's Disease: Report of a Case

1 reference

12 December 2020

Carcinoma arising in enterocutan fistulae of Crohn's disease patients: description of two cases

1 reference

12 December 2020

Demyelination-like syndrome in Crohn's disease after infliximab therapy

1 reference

12 December 2020

Identifiers

DOI

10.4251/WJGO.V2.I7.307

1 reference

27 September 2017

1 reference

27 September 2017

PubMed publication ID

21160662

1 reference